Written by the Neoi - Health Supplements Singapore editorial team - Last updated: 7 August 2026
HSA dealer records are product, batch, distribution, incident and claim-evidence files that Singapore guidance places with health-supplement dealers. They support accountability, not public approval or individual suitability. This guide explains the record layers without assessing a product or giving medical advice.
Read dealer responsibility correctly
HSA's regulatory overview says health supplements are not subject to its approval and licensing for importation, manufacture and sale. It places the obligation to meet applicable safety and quality standards on importers, manufacturers, wholesale dealers and sellers.
HSA says a company using voluntary notification should self-assess supporting information and hold it on file so compliance can be demonstrated when requested. The overview does not say every underlying record must be public. A listing, label and internal file answer different questions.
Map the six product-record groups
Original element 1, captured on 7 August 2026: section 4.7 of HSA's January 2026 Health Supplements Guidelines lists six groups of product-related information dealers should hold. This table reorganises them by question.
| Record group | HSA guideline detail | Question it can answer |
|---|---|---|
| Ingredient source | Manufacturer name and country for each ingredient | Who made each ingredient, and where? |
| Finished-product source | Manufacturer name and country for the finished product | Who made the final dosage form, and where? |
| Active-ingredient analysis | Certificate of Analysis with test parameters, specifications and method references for each active ingredient | What was checked against which specification and method? |
| Finished-batch evidence | Product specification and Certificate of Analysis for every finished-product batch | Does the evidence identify this finished batch? |
| Distribution trail | Product distribution records | Where did the relevant product or batch move? |
| Incident history | Reported adverse-event, product-defect and recall records | What issues were recorded and how were they handled? |
The guideline addresses dealers. It does not say a seller must hand over every document on demand. Use it to understand why batch number, report date and complete context matter.
Separate three evidence layers
Original element 2, captured on 7 August 2026: the HSA overview, guideline and claims guidance support a three-layer evidence map.
- Label-visible layer: product name, active ingredients and quantities, batch number, expiry date, country of manufacture, local importer or product-owner details, warnings, storage and pack size can be checked on the actual pack.
- Seller-provided layer: a seller may provide label images, a batch-linked Certificate of Analysis or an explanation of a claim. Check whether the file identifies the same product and batch; do not rely on a cropped result column.
- Regulator-facing layer: ingredient-safety evidence, product specifications, distribution and incident records, and claim substantiation may be held by the dealer for HSA when requested. Their absence from a public page is not proof that they do not exist.
HSA's claims page also says claim evidence is the dealer's responsibility. Its claims guideline says substantiation should be relevant and held at all times; generic search results, product blogs, testimonials, animal-only studies and in-vitro-only studies are not accepted there as claim substantiation.
Use a seven-step record check
- Match the exact product and brand name across the pack, listing and any document.
- Match the batch number; evidence for another batch does not describe the pack in hand.
- Record the report date and keep the complete page set, not a screenshot fragment.
- Identify the tested parameter, numerical result, unit, specification and method reference where shown.
- Separate ingredient analysis from finished-product analysis instead of treating them as interchangeable.
- Compare marketing claims with the cited evidence and HSA's permitted-claim boundaries.
- If the evidence remains unclear, pause the purchase or ask the seller a narrow written question.
The March 2026 HSA safety and quality Q&A describes recommended test results as batch specific and reflected in the batch Certificate of Analysis. This supports a batch-match check; it does not authenticate a document or replace laboratory review.
Know what records cannot prove
A Certificate of Analysis does not by itself prove seller identity, authenticity, appropriate storage, efficacy or personal suitability. A voluntary-notification match does not mean HSA endorsement. A clean public search does not show that every internal record is complete, while a record not posted publicly does not prove non-compliance.
Keep conclusions narrow and observable: the label does or does not show a field; a document does or does not match the named product and batch; a claim does or does not identify relevant support. For symptoms, medicine interactions, pregnancy, surgery or individual use, ask a qualified doctor or pharmacist rather than interpreting dealer files alone.
FAQ
Does HSA approve these records before every supplement is sold? No. HSA states that health supplements are not subject to pre-market approval and licensing for importation, manufacture and sale. Dealers remain responsible for conformity with applicable standards.
Must a retailer publish every Certificate of Analysis? The cited HSA guidance tells dealers what information to hold; it does not say every underlying document must be public. Ask what is available, then label any gap as unknown rather than proof of failure.
Can one Certificate of Analysis cover every batch? Do not assume so. HSA's Q&A describes recommended test results as batch specific and reflected in the batch Certificate of Analysis.
Does a file of records prove a supplement will work for me? No. Compliance and traceability records do not establish individual efficacy, medical suitability or freedom from interaction risk.
This article is general educational information about HSA dealer records for health supplements in Singapore. It is not medical advice, legal advice, regulatory clearance, laboratory interpretation or a product recommendation. Official guidance can change; check the current HSA sources and seek qualified advice for health concerns.
Related reading on this site: Regulatory landscape - Definitions - VNS list check - HSA contaminant limits
Sources
- HSA - Regulatory overview of health supplements (accessed 7 August 2026): https://www.hsa.gov.sg/health-supplements/overview/
- HSA - Health supplement claims (accessed 7 August 2026): https://www.hsa.gov.sg/health-supplements/claims/
- HSA - Health Supplements Guidelines, January 2026 (accessed 7 August 2026): https://file.go.gov.sg/hsa-hs-guidelines.pdf
- HSA - Guidelines for Claims and Claims Substantiation of Health Supplements and Traditional Medicines, January 2025 (accessed 7 August 2026): https://file.go.gov.sg/hsa-chp-claims-guidelines.pdf
- HSA - Q&A on Safety and Quality for Health Supplements and Traditional Medicines, March 2026 (accessed 7 August 2026): https://file.go.gov.sg/hsa-chp-safety-quality-qna.pdf